BAVARIAN NORDIC A/SBAVARIAN NORDIC A/SBAVARIAN NORDIC A/S

BAVARIAN NORDIC A/S

No trades
See on Supercharts
Market capitalization
‪11.98 B‬DKK
‪1.48 B‬DKK
‪7.06 B‬DKK
‪77.68 M‬
Beta (1Y)
0.95

About BAVARIAN NORDIC A/S

CEO
Paul Chaplin
Headquarters
Hellerup
Employees (FY)
‪1.38 K‬
Founded
1992
ISIN
DK0015998017
FIGI
BBG000FX2HV6
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BAVA is 150.10 DKK — it has decreased by 2.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange BAVARIAN NORDIC A/S stocks are traded under the ticker BAVA.
BAVARIAN NORDIC A/S is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for BAVARIAN NORDIC A/S has a max estimate of 345.00 DKK and a min estimate of 170.00 DKK.
BAVA earnings for the last quarter are −4.40 DKK whereas the estimation was 5.87 DKK which accounts for −175.00% surprise. Estimated earnings for the next quarter are 9.08 DKK. See more details about BAVARIAN NORDIC A/S earnings.
BAVARIAN NORDIC A/S revenue for the last quarter amounts to ‪1.38 B‬ DKK despite the estimated figure of ‪1.78 B‬ DKK. In the next quarter revenue is expected to reach ‪2.36 B‬ DKK.
Yes, you can track BAVARIAN NORDIC A/S financials in yearly and quarterly reports right on TradingView.
Like other stocks, BAVA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAVARIAN NORDIC A/S stock right from TradingView charts — choose your broker and connect to your account.
BAVA reached its all-time high on Aug 5, 2022 with the price of 411.00 DKK, and its all-time low was 18.35 DKK and was reached on Sep 30, 2002.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪1.38 K‬ employees. See our rating of the largest employees — is BAVARIAN NORDIC A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAVARIAN NORDIC A/S EBITDA is ‪2.05 B‬ DKK, and current EBITDA margin is 29.07%. See more stats in BAVARIAN NORDIC A/S financial statements.